Osso VR Expands Virtual Reality Training in Orthopedic Subspecialties
New modules introduce hyper-realistic content providing trainees access to one of the largest orthopedic virtual reality training libraries with 30+...
Jan 18, 2024,
Osso VR Expands Virtual Reality Training in Orthopedic Subspecialties
Accelus Closes $20 Million Debt Facility
The infusion will support salesforce expansion in underpenetrated markets and accelerate clinical research and product development efforts....
Jan 18, 2024,
Stryker Expands the Gamma4 Hip Fracture Nailing System
Expansions to the Gamma4 Hip Fracture Nailing System include an intermediate nail, RC Lag Screw and an anti-rotation clip with...
Jan 17, 2024,
Limited Launch of Paragon 28 Bun-Yo-Matic
Bun-Yo-Matic is the company's next-generation clamp and cut guide system for lapidus bunion procedures....
Jan 17, 2024,
Bolt Navigation Closes Series B Financing
Funds will support commercialization and new application development of the Bolt Navigation System for spine surgeries....
Jan 17, 2024,
Burning Questions for the Top Orthopedic Players in 2024
Public orthopedic companies with over $2 billion in annual sales control more than 60% of the market, but face questions...
Jan 17, 2024,
Xenco Medical Unveils the TrabeculeX Continuum
Comprising the TrabeculeX Bioactive Matrix and TrabeculeX Recovery App, the TrabeculeX Continuum is a technology-enabled bridge between orthobiologics and digital...
Jan 16, 2024,
restor3d Completes Key Initiative Following Conformis Acquisition
Patient-specific femoral implants, which were traditionally cast at low margin, are now 3D-printed at a fraction of the cost at...
Jan 16, 2024,
Biocomposites Expands Presence in Italy
Biocomposites SRL will support sales of STIMULAN, NanoBone, genex and SYNICEM Spacers throughout Italy....
Jan 16, 2024,
One Surgeon’s Quest to Advance Rotator Cuff Repair
Dr. Stefan Welte believes that understanding of the body’s biological response will lead to innovative rotator cuff repair solutions...
Jan 12, 2024,
Loading new posts...
No more posts
